Parity and age at first childbirth in relation to the risk of different breast cancer subgroups

International Journal of Cancer

Volumn 125, Issue 8, 2009, Pages 1926-1934

  Butt, Salma ^a   Borgquist, Signe ^a,b   Anagnostaki, Lola ^b   Landberg, Göran ^b   Manjer, Jonas ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Malmö University Hospital   (Sweden)

Author keywords

Age at diagnosis; Breast cancer risk; Parity; Stage; Subgroups

Indexed keywords

CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P27; CCND1 PROTEIN, HUMAN; ESTROGEN RECEPTOR; HER2 PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CANCER INVASION; CANCER REGISTRY; CANCER RISK; CHILDBIRTH; COHORT ANALYSIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NULLIPARA; PARITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR VOLUME; AGE; BREAST TUMOR; CARCINOMA IN SITU; CELL PROLIFERATION; CLASSIFICATION; ESTROGEN THERAPY; LUNG CARCINOMA; LYMPH NODE; LYMPH NODE METASTASIS; MENOPAUSE; METABOLISM; MIDDLE AGED; PATHOLOGY; PREGNANCY; PROGNOSIS; RISK FACTOR;

ADULT; AGE FACTORS; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; CELL PROLIFERATION; CYCLIN D1; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MENOPAUSE; MIDDLE AGED; NEOPLASM INVASIVENESS; PARITY; PREGNANCY; PROGNOSIS; PROSPECTIVE STUDIES; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; YOUNG ADULT;

EID: 70349257990     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24494     Document Type: Article

References (36)

1. Albrektsen G, Heuch I, Hansen S, Kvale G. Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer 2005;92:167-175 (Pubitemid 40188451)
2. Albrektsen G, Heuch I, Tretli S, Kvale G. Breast cancer incidence before age 55 in relation to parity and age at first and last births: a prospective study of one million Norwegian women. Epidemiology 1994;5:604-611 (Pubitemid 24336512)
3. Wohlfahrt J, Andersen PK, Mouridsen HT, Melbye M. Risk of late-stage breast cancer after a childbirth. Am J Epidemiol 2001;153:1079-1084 (Pubitemid 32493256)
4. Britt K, Ashworth A, Smalley M. Pregnancy and the risk of breast cancer. Endocr Relat Cancer 2007;14:907-933
5. Hinkula M, Pukkala E, Kyyronen P, Kauppila A. Grand multiparity and the risk of breast cancer: population-based study in Finland. Cancer Causes Control 2001;12:491-500. (Pubitemid 32735121)
6. Butt S, Borgquist S, Garne JP, Landberg G, Tengrup I, Olsson A, Manjer J. Parity in relation to survival following breast cancer. Eur J Surg Oncol 2009;35:702-708
7. Kroman N, Wohlfahrt J, Andersen KW, Mouridsen HT, Westergaard T, Melbye M. Parity, age at first childbirth and the prognosis of primary breast cancer. Br J Cancer 1998;78:1529-1533 (Pubitemid 28517553)
8. Manjer J, Carlsson S, Elmstahl S, Gullberg B, Janzon L, Lindstrom M, Mattisson I, Berglund G. The Malmo Diet and Cancer Study: representativity, cancer incidence and mortality in participants and nonparticipants. Eur J Cancer Prev 2001;10:489-499 (Pubitemid 34048904)
9. Manjer J, Elmstahl S, Janzon L, Berglund G. Invitation to a population- based cohort study: differences between subjects recruited using various strategies. Scand J Public Health 2002;30:103-112 (Pubitemid 41007501)
10. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-410
11. Borgquist S, Anagnostaki L, Jirstrom K, Landberg G, Manjer J. Breast tumours following combined hormone replacement therapy express favourable prognostic factors. Int J Cancer 2007;120:2202-2207 (Pubitemid 46555859)
12. Borgquist S, Wirfalt E, Jirstrom K, Anagnostaki L, Gullberg B, Berglund G, Manjer J, Landberg G. Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators. Breast Cancer Res 2007;9:R11. (Pubitemid 350215150)
13. Dowsett M, Bartlett J, Ellis IO, Salter J, Hills M, Mallon E, Watters AD, Cooke T, Paish C, Wencyk PM, Pinder SE. Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres. J Pathol 2003;199:418-423 (Pubitemid 36411217)
14. Brittain AW. Can women remember how many children they have borne? Data from the east. Caribbean Soc Biol 1991;38:219-232
15. Garne JP. Invasive breast cancer in Malmö 1961-1992-an epidemiological study. Dissertation, Lund University, Malmö 1996.
16. Lash TL, Fink AK. Null association between pregnancy termination and breast cancer in a registry-based study of parous women. Int J Cancer 2004;110:443-448
17. Michels KB, Xue F, Colditz GA, Willett WC. Induced and spontaneous abortion and incidence of breast cancer among young women: a prospective cohort study. Arch Intern Med 2007;167:814-820 (Pubitemid 46658340)
18. Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, Kaufman JS, Moorman PG, Cai J, Olshan AF, Porter PL, Brinton LA, Eley JW, et al. Association between reproductive factors and breast cancer survival in younger women. Breast Cancer Res Treat 2007;103:93-102. (Pubitemid 46653261)
19. Hoos A, Cordon-Cardo C. Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest 2001;81:1331-1338 (Pubitemid 32980155)
20. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000;80:1943-1949
21. Clavel-Chapelon F. Cumulative number of menstrual cycles and breast cancer risk: results from the E3N cohort study of French women. Cancer Causes Control 2002;13:831-838 (Pubitemid 35305202)
22. Daling JR, Malone KE, Doody DR, Anderson BO, Porter PL. The relation of reproductive factors to mortality from breast cancer. Cancer Epidemiol Biomarkers Prev 2002;11:235-241 (Pubitemid 34326999)
23. Ma H, Bernstein L, Pike MC, Ursin G. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res 2006;8:R43. (Pubitemid 44057560)
24. Ursin G, Bernstein L, Lord SJ, Karim R, Deapen D, Press MF, Daling JR, Norman SA, Liff JM, Marchbanks PA, Folger SG, Simon MS, et al. Reproductive factors and subtypes of breast cancer defined by hormone receptor and histology. Br J Cancer 2005;93:364-371 (Pubitemid 43080039)
25. Albrektsen G, Heuch I, Thoresen S, Kvale G. Clinical stage of breast cancer by parity, age at birth, and time since birth: a progressive effect of pregnancy hormones? Cancer Epidemiol Biomarkers Prev 2006;15:65-69
26. Albrektsen G, Heuch I, Thoresen S, Kvale G. Family history of breast cancer and short-term effects of childbirths on breast cancer risk. Int J Cancer 2006;119:1468-1474 (Pubitemid 44258827)
27. Hsieh CC, Chan HW, Lambe M, Ekbom A, Adami HO, Trichopoulos D. Does age at the last birth affect breast cancer risk? Eur J Cancer 1996;32A:118-121
28. Rosenberg LU, Einarsdottir K, Friman EI, Wedren S, Dickman PW, Hall P, Magnusson C. Risk factors for hormone receptor-defined breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006;15:2482-2488 (Pubitemid 46048309)
29. Kaplan HG, Malmgren JA. Impact of triple negative phenotype on breast cancer prognosis. Breast J 2008;14:456-463
30. Reis-Filho JS, Tutt AN. Triple negative tumours: a critical review. Histopathology 2008;52:108-118
31. Lagerlund M, Maxwell AE, Bastani R, Thurfjell E, Ekbom A, Lambe M. Sociodemographic predictors of non-attendance at invitational mammography screening-a population-based register study (Sweden). Cancer Causes Control 2002;13:73-82. (Pubitemid 34163953)
32. Russo J, Moral R, Balogh GA, Mailo D, Russo IH. The protective role of pregnancy in breast cancer. Breast Cancer Res 2005;7:131-142 (Pubitemid 40704134)
33. Kroman N, Wohlfahrt J, Andersen KW, Mouridsen HT, Westergaard T, Melbye M. Time since childbirth and prognosis in primary breast cancer: population based study. BMJ 1997;315:851-855 (Pubitemid 27420444)
34. Russo J, Reina D, Frederick J, Russo IH. Expression of phenotypical changes by human breast epithelial cells treated with carcinogens in vitro. Cancer Res 1988;48:2837-2857 (Pubitemid 18137761)
35. Russo J, Balogh GA, Russo IH. Full-term pregnancy induces a specific genomic signature in the human breast. Cancer Epidemiol Biomarkers Prev 2008;17:51-66. (Pubitemid 351196273)
36. D'Cruz CM, Moody SE, Master SR, Hartman JL, Keiper EA, Imielinski MB, Cox JD, Wang JY, Ha SI, Keister BA, Chodosh LA. Persistent parity-induced changes in growth factors. TGF-beta3, and differentiation in the rodent mammary gland. Mol Endocrinol 2002;16:2034-2051